Metraipolis › archive › dc_4bfaecdea4c3
The genomic landscape of metastasis in treatment-naïve breast cancer models — Europe PMC PMID:32463822
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32463822
- DOI
- 10.1371/journal.pgen.1008743
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-08T15:56:39.298Z
- SHA-256 of the archived text
b2ef71901714060c6524cbf7e9669d1f7384e356ed90cb5d39907c6198926c22- Stable URL of this page
https://metraipolis.com/documento/dc_4bfaecdea4c3
How to cite
The genomic landscape of metastasis in treatment-naïve breast cancer models — Europe PMC PMID:32463822 — Europe PMC (en), https://europepmc.org/article/MED/32463822 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_4bfaecdea4c3 (Metraipolis archive dc_4bfaecdea4c3, sha256 b2ef71901714060c6524cbf7e9669d1f7384e356ed90cb5d39907c6198926c22)
BibTeX
@misc{dc4bfaecdea4c3,
title = {The genomic landscape of metastasis in treatment-naïve breast cancer models — Europe PMC PMID:32463822},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32463822},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_4bfaecdea4c3; sha256 b2ef71901714060c6524cbf7e9669d1f7384e356ed90cb5d39907c6198926c22},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32463822. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Metastasis remains the principle cause of mortality for breast cancer and presents a critical challenge because secondary lesions are often refractory to conventional treatments. While specific genetic alterations are tightly linked to primary tumor development and progression, the role of genetic alteration in the metastatic process is not well-understood. The theory of tumor evolution postulated by Peter Nowell in 1976 has yet to be proven in the context of metastasis. Therefore, in order to investigate how somatic evolution contributes to breast cancer metastasis, we performed exome, whole genome, and RNA sequencing of matched metastatic and primary tumors from pre-clinical mouse models of breast cancer. Here we show that in a treatment-naïve setting, recurrent single nucleotide variants and copy number variation, but not gene fusion events, play key metastasis-driving roles in breast cancer. For instance, we identified recurrent mutations in Kras, a known driver of colorectal and lung tumorigenesis that has not been previously implicated in breast cancer metastasis. However, in a set of in vivo proof-of-concept experiments we show that the Kras G12D mutation is sufficient to significantly promote metastasis using three syngeneic allograft models. The work herein confirms the existence of metastasis-driving mutations and presents a novel framework to identify actionable metastasis-targeted therapies. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS genetics, 2020 (prima pubblicazione 2020-05-28). Identificativi: PMID 32463822 · PMCID PMC7282675 · DOI 10.1371/journal.pgen.1008743. Descrittori MeSH principali: Mutation. Pagina: https://europepmc.org/article/MED/32463822 — https://doi.org/10.1371/journal.pgen.1008743. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-08T15:52:55.910Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.